SCHEMBL6006263

SCHEMBL6006263

O=C(O)c1cccc([N+](=O)[O-])c1N1C(=O)CCC1=O

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.56
DNA2 P51530 1/20 0.44
CASP6 P55212 1/20 0.44
CTDSP1 Q9GZU7 1/20 0.44
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ALDH1A1 P00352 4/20 0.42
MEN1 O00255 2/20 0.42
GAA P10253 2/20 0.42
MAPT P10636 2/20 0.42
KMT2A Q03164 2/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.40
GPR35 Q9HC97 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5222827 0.80 TSHR (0.50) TSHRDNA2CASP6CTDSP1TDP1
SCHEMBL3729139 0.78 TSHR (0.46) TSHRDNA2CASP6CTDSP1TDP1
SCHEMBL317655 0.75 ALB (0.49) ALDH1A1GAAKMT2AHPGD
SCHEMBL17769843 0.75 TSHR (0.51) TSHRDNA2CASP6CTDSP1TDP1
SCHEMBL15714747 0.75 TSHR (0.62) TSHRDNA2CASP6CTDSP1TDP1
SCHEMBL16653775 0.74 KDM4E (0.57) TSHRL3MBTL1ALDH1A1MEN1MAPT
SCHEMBL33663 0.73 TSHR (1.00) TSHRTDP1L3MBTL1ALDH1A1MEN1
SCHEMBL28969704 0.72 CA12 (0.35) TSHRDNA2CASP6CTDSP1TDP1
SCHEMBL29471725 0.72 TSHR (0.68) TSHRDNA2CASP6CTDSP1TDP1
SCHEMBL8610738 0.72 TSHR (0.68) TSHRDNA2CASP6CTDSP1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1667728-A1 INTRAVASCULAR DELIVERY OF NON-VIRAL NUCLEIC ACID Mirus Bio Corporation (US) 2006-06-14 EP disclosed
WO-2005009476-A1 INTRAVASCULAR DELIVERY OF NON-VIRAL NUCLEIC ACID MIRUS CORPORATION (US) 2005-02-03 WO disclosed